Publisher's Synopsis
Symptomatic benign prostatic hyperplasia (BPH) as characterized by lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO) is a common condition in the elderly male population. Although there are some country-specific differences, symptomatic BPH in general occurs in approximately 25 per cent of men aged 40 years or over and in one in every three men over 65 years. However, there exists considerable differences in the management of symptomatic BPH across Europe and between Europe and the US.;The papers in this book were presented at a satellite symposium held during the 14th Congress of the European Association of Urology (EAU) on April 7th, 1999, in Stockholm. They elaborate on contemporary management of symptomatic BPH in the US and some major European countries such as France, Germany, Italy and the United Kingdom. Certain themes are evident from the data presented in the book, and topics discussed include healthcare providers involved in the management of symptomatic BPH, surgical and medical management of symptomatic BPH and evidence-based medicine.